期刊文献+

历代成方制剂及现代临床处方中细辛用量的调查与分析 被引量:6

The Investigation and Analysis on the Dosage of Herba Asari in the Historical Preparations and the Present Clinical Prescriptions
暂未订购
导出
摘要 目的 :了解历代成方制剂及现代临床处方中细辛的用量。方法 :调查了《方剂学》、现行《药典》中的成方、临床中药汤剂含有细辛的处方。结果 :古、近代多数处方中细辛的用量是现行《药典》上限用量的 6倍~ 14倍 ;临床汤剂处方在《药典》范围内的占 4 7 5 %。结论 :古、近代、现代临床处方中细辛用量与现行《药典》规定的用量相距甚远。 OBJECTIVE: To comprehend the dosage of Herba Asari in the historical preparations and the present clinical prescriptions. METHODS:To investigate the prescriptions of TCM,The present pharmacopoeia and the clinical decoction prescriptions which comprise Herba Asari. RESULTS:The dosage of Herba Asari in ancient and modern times prescriptions is as six to fourteen times as the maximum of the present pharmacopoeia. It comprises 47.5% that the clinical prescriptions which dosage is in the scope of pharmacopoeia. CONCLUSION: The dosage of Herba Asari in ancient,modern and present times prescriptions is far away from the regulation dosage of pharmacopoeia.
出处 《中国实验方剂学杂志》 CAS 2003年第6期55-57,共3页 Chinese Journal of Experimental Traditional Medical Formulae
关键词 细辛 历代用量 区别较大 Herba Asari Dosage of Successive(past)dynasties More different
  • 相关文献

参考文献3

  • 1江苏新医学院.中药大辞典(上册)[M].上海:上海科技出版社,1986.1340.
  • 2辞海委员会.辞海(缩印本)[M].上海:上海辞书出版社,1979.1160,1087.
  • 3吴伯平.2001.6.20FDA关于收回13种中成药的公告[J].中国中医药信息杂志,2001,8(8):30-30.

共引文献88

同被引文献57

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部